Company – Scrape Financial
Risk Factors Summary

Risk Factors Update Summary

  • Risks associated with the ongoing conflict between Russia and Ukraine were added as a new risk factor.
  • HHS rule change allows states to import drugs from Canada. Florida FDA approval for importing certain drugs.
  • Risks related to the disruption in the global economy caused by the conflict between Israel and Hamas were included.
  • Investor ownership decreased from 9.59% to 5%. Impairments to finite-lived intangible assets: $54M to $15M.
  • The potential impact of inflation and macroeconomic factors on the company's operations was highlighted.
  • Impairments to goodwill: Neurology and Other & Ortho Dermatologics units: $493M to $824M.
  • The company may incur significant expenses in connection with the B + L Separation, with ongoing costs.
  • Goodwill impairments: Ortho Dermatologics unit: $146M to $18M. Generics reporting unit goodwill impairment: $91M.
  • Changes in tax laws, such as the Inflation Reduction Act, could affect the company's tax rate.
  • The company faces risks related to intellectual property, acquisitions, and integration challenges.
  • Risks associated with catastrophic events, cybersecurity incidents, and information technology were emphasized.

Full Text Changes in Most Recent 10-K

Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.

To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=885590&owner=exclude

Click here to download the PDF